Evidence map›Paper›PMID 26820595›Full record

ArticleNeuroscience2016

Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.

M Yepes, F Wu, E Torre, D Cuellar-Giraldo, D Jia, L Cheng

Abstract read
In one paragraph

Article in Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M YepesDepartment of Neurology & Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA; Department of Neurology, Veterans Affairs Medical Center, Atlanta, GA, USA. Electronic address: myepes@emory.edu.
F WuDepartment of Neurology & Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA.
E TorreDepartment of Neurology & Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA.
D Cuellar-GiraldoDepartment of Neurology & Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA.
D JiaDepartment of Neurology & Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA.
L ChengDepartment of Neurology & Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA.
Emory University · US

Funding

Urokinase-type Plasminogen Activator in the Ischemic BrainR01NS091201 · NINDS · EMORY UNIVERSITY · PI YEPES, MANUEL SALVADOR · 2015 to 2022
$2.7M
tPA is a Neuroprotectant in the Ischemic BrainR01NS079331 · NINDS · EMORY UNIVERSITY · PI YEPES, MANUEL SALVADOR · 2013 to 2017
$1.7M
NINDS NIH HHS NS-079331NINDS NIH HHS NS-091201NINDS NIH HHS R01 NS079331NINDS NIH HHS R01 NS091201
6 · The paper itself

Abstract

The release of the serine proteinase tissue-type plasminogen activator (tPA) from the presynaptic terminal of cerebral cortical neurons plays a central role in the development of synaptic plasticity, adaptation to metabolic stress and neuronal survival. Our earlier studies indicate that by inducing the recruitment of the cytoskeletal protein βII-spectrin and voltage-gated calcium channels to the active zone, tPA promotes Ca(2+)-dependent translocation of synaptic vesicles (SVs) to the synaptic release site where they release their load of neurotransmitters into the synaptic cleft. Here we used a combination of in vivo and in vitro experiments to investigate whether this effect leads to depletion of SVs in the presynaptic terminal. Our data indicate that tPA promotes SV endocytosis via a mechanism that does not require the conversion of plasminogen into plasmin. Instead, we show that tPA induces calcineurin-mediated dynamin I dephosphorylation, which is followed by dynamin I-induced recruitment of the actin-binding protein profilin II to the presynaptic membrane, and profilin II-induced F-actin formation. We report that this tPA-induced sequence of events leads to the association of newly formed SVs with F-actin clusters in the endocytic zone. In summary, the data presented here indicate that following the exocytotic release of neurotransmitters tPA activates the mechanism whereby SVs are retrieved from the presynaptic membrane and endocytosed to replenish the pool of vesicles available for a new cycle of exocytosis. Together, these results indicate that in murine cerebral cortical neurons tPA plays a central role coupling SVs exocytosis and endocytosis.

Indexed as

AnimalsBlotting, WesternCells, CulturedCerebral CortexEndocytosisImmunohistochemistryMaleMiceMice, Inbred C57BLMicroscopy, ConfocalNeuronal PlasticityNeuronsSynaptic VesiclesTissue Plasminogen ActivatorTissue Plasminogen Activatorendocytosisplasminplasminogensynaptic vesiclestissue-type plasminogen activator

Identifiers

PMID26820595
PMCPMC4762727
OpenAlexW2252130947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.